Interpace Biosciences (IDXG) Current Ratio
Price: $2.005
Market Cap: $8.83M
Avg Volume: 7.93K
Market Cap: $8.83M
Avg Volume: 7.93K
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Interpace Biosciences Current Ratio
- Annual: 0.59
- Quarterly: 0.53
- TTM: 0.53
What is the Current Ratio?
The current ratio is a liquidity ratio that measures a company's ability to pay off its short-term liabilities with its short-term assets. A higher current ratio indicates a greater ability to meet short-term obligations.
Related Metrics
Other important metrics to assess Interpace Biosciences's financial health include:
- Quick Ratio - measures the company's ability to meet short-term obligations with its most liquid assets:
- Annual: 0.52
- Quarterly: 0.47
- TTM: 0.47
- Cash Ratio - measures the company's ability to pay off short-term liabilities with cash and cash equivalents:
- Annual: 0.20
- Quarterly: 0.11
- TTM: 0.11
These metrics provide insights into Interpace Biosciences's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Current Ratio
0.59
Quarterly Current Ratio
0.53
TTM Current Ratio
0.53
Interpace Biosciences Historical Current Ratio
Historical Quick Ratio
Historical Cash Ratio
Interpace Biosciences Historical Ratios
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.
Year | Current Ratio | Quick Ratio | Cash Ratio |
---|---|---|---|
2023 | 0.59 | 0.52 | 0.20 |
2022 | 0.85 | 0.77 | 0.34 |
2021 | 0.78 | 0.66 | 0.21 |
2020 | 0.77 | 0.66 | 0.15 |
2019 | 0.95 | 0.84 | 0.13 |
2018 | 2.09 | 1.94 | 0.71 |
2017 | 2.48 | 2.45 | 1.90 |
2016 | 0.26 | 0.26 | 0.04 |
2015 | 0.82 | 0.58 | 0.36 |
2014 | 1.34 | 1.34 | 0.69 |